As of 2025-12-20, the Fair Value of Johnson & Johnson (JNJ) is 127.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 206.37 USD, the upside of Johnson & Johnson is -38.27%.
With the market price of 206.37 USD and our fair value calculation, Johnson & Johnson (JNJ) is not a good investment. Investing in JNJ stocks now will result in a potential loss of 38.27%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-01-03 | 2022-01-02 | 2023-01-01 | 2023-12-31 | 2024-12-29 | 5Y Avg | |
| Net income | 14,714.00 | 20,878.00 | 17,941.00 | 35,153.00 | 14,066.00 | 20,550.40 |
| YoY growth | -2.68% | 41.89% | -14.07% | 95.94% | -59.99% | 12.22% |
| Market Cap (mil) | 497,207.25 |
| P/E | 19.79x |
| Forward P/E | 29.95x |
| EPS | 10.43 |
| Avg earnings growth rate | 12.22% |
| TTM earnings | 25,119.00 |